Literature DB >> 1570319

A mutant p53 protein is required for maintenance of the transformed phenotype in cells transformed with p53 plus ras cDNAs.

G P Zambetti1, D Olson, M Labow, A J Levine.   

Abstract

Mutant p53 and activated ras cDNA clones cooperate to fully transform primary rat embryo fibroblasts in cell culture, whereas neither cDNA alone results in the full transformation of these cells. The mutant p53 protein may be required to initiate the transformation event with ras. Alternatively, mutant p53 gene expression may be required to maintain the properties of the transformed phenotype. To distinguish between these possibilities, primary rat embryo fibroblasts were transformed with mutant p53 plus ras cDNAs, where the expression of the p53 gene was regulated by an isopropyl beta-D-thiogalactoside-responsive promoter. When expression of the mutant p53 cDNA was inhibited and no detectable exogenous p53 protein was produced, both the growth rate and the morphology of the cells reverted to a normal phenotype. These results demonstrate that a mutant p53 protein is required for the maintenance of the transformed phenotype in cells transformed with p53 plus ras cDNAs.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1570319      PMCID: PMC525609          DOI: 10.1073/pnas.89.9.3952

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  28 in total

1.  Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53.

Authors:  D Michalovitz; O Halevy; M Oren
Journal:  Cell       Date:  1990-08-24       Impact factor: 41.582

2.  Overproduction of p53 antigen makes established cells highly tumorigenic.

Authors:  D Eliyahu; D Michalovitz; M Oren
Journal:  Nature       Date:  1985 Jul 11-17       Impact factor: 49.962

3.  Association of human papillomavirus types 16 and 18 E6 proteins with p53.

Authors:  B A Werness; A J Levine; P M Howley
Journal:  Science       Date:  1990-04-06       Impact factor: 47.728

4.  Conversion of the lac repressor into an allosterically regulated transcriptional activator for mammalian cells.

Authors:  M A Labow; S B Baim; T Shenk; A J Levine
Journal:  Mol Cell Biol       Date:  1990-07       Impact factor: 4.272

5.  Suppression of human colorectal carcinoma cell growth by wild-type p53.

Authors:  S J Baker; S Markowitz; E R Fearon; J K Willson; B Vogelstein
Journal:  Science       Date:  1990-08-24       Impact factor: 47.728

6.  Negative growth regulation in a glioblastoma tumor cell line that conditionally expresses human wild-type p53.

Authors:  W E Mercer; M T Shields; M Amin; G J Sauve; E Appella; J W Romano; S J Ullrich
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

7.  Reconstitution of p53 expression in a nonproducer Ab-MuLV-transformed cell line by transfection of a functional p53 gene.

Authors:  D Wolf; N Harris; V Rotter
Journal:  Cell       Date:  1984-08       Impact factor: 41.582

8.  Cellular immortalization by a cDNA clone encoding the transformation-associated phosphoprotein p53.

Authors:  J R Jenkins; K Rudge; G A Currie
Journal:  Nature       Date:  1984 Dec 13-19       Impact factor: 49.962

9.  Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas.

Authors:  S J Baker; E R Fearon; J M Nigro; S R Hamilton; A C Preisinger; J M Jessup; P vanTuinen; D H Ledbetter; D F Barker; Y Nakamura; R White; B Vogelstein
Journal:  Science       Date:  1989-04-14       Impact factor: 47.728

10.  Cooperation between gene encoding p53 tumour antigen and ras in cellular transformation.

Authors:  L F Parada; H Land; R A Weinberg; D Wolf; V Rotter
Journal:  Nature       Date:  1984 Dec 13-19       Impact factor: 49.962

View more
  17 in total

1.  Alternatively spliced forms in the carboxy-terminal domain of the p53 protein regulate its ability to promote annealing of complementary single strands of nucleic acids.

Authors:  L Wu; J H Bayle; B Elenbaas; N P Pavletich; A J Levine
Journal:  Mol Cell Biol       Date:  1995-01       Impact factor: 4.272

2.  Identification of a novel p53 functional domain that is necessary for efficient growth suppression.

Authors:  K K Walker; A J Levine
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-24       Impact factor: 11.205

3.  p53-mediated cell death: relationship to cell cycle control.

Authors:  E Yonish-Rouach; D Grunwald; S Wilder; A Kimchi; E May; J J Lawrence; P May; M Oren
Journal:  Mol Cell Biol       Date:  1993-03       Impact factor: 4.272

4.  The amino-terminal functions of the simian virus 40 large T antigen are required to overcome wild-type p53-mediated growth arrest of cells.

Authors:  R S Quartin; C N Cole; J M Pipas; A J Levine
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

5.  Abrogation of oncogene-associated apoptosis allows transformation of p53-deficient cells.

Authors:  S W Lowe; T Jacks; D E Housman; H E Ruley
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-15       Impact factor: 11.205

6.  Regulation of synoviocyte proliferation, apoptosis, and invasion by the p53 tumor suppressor gene.

Authors:  K R Aupperle; D L Boyle; M Hendrix; E A Seftor; N J Zvaifler; M Barbosa; G S Firestein
Journal:  Am J Pathol       Date:  1998-04       Impact factor: 4.307

7.  Cell transformation by c-fos requires an extended period of expression and is independent of the cell cycle.

Authors:  G G Miao; T Curran
Journal:  Mol Cell Biol       Date:  1994-06       Impact factor: 4.272

8.  Modulation of cellular and viral promoters by mutant human p53 proteins found in tumor cells.

Authors:  S Deb; C T Jackson; M A Subler; D W Martin
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

9.  Gain-of-function mutations of the p53 gene induce lymphohematopoietic metastatic potential and tissue invasiveness.

Authors:  M Hsiao; J Low; E Dorn; D Ku; P Pattengale; J Yeargin; M Haas
Journal:  Am J Pathol       Date:  1994-09       Impact factor: 4.307

10.  Expression of transduced tropomyosin 1 cDNA suppresses neoplastic growth of cells transformed by the ras oncogene.

Authors:  G L Prasad; R A Fuldner; H L Cooper
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.